IP Library Granted Patent US 9,408,728
Granted Patent B2
US 9,408,728 · App. 14/791,617 · Granted Aug 9, 2016

Procedures for vascular occlusion

Inventors: Aaron Berez (Portola Valley, CA); Quang Tran (Atherton, CA)
Assignee: Covidien LP
A61F2/82A61F2/852A61F2/90A61F2/95A61F2002/823A61F2002/826A61F2002/9528A61F2230/0078A61F2230/0091A61F2230/0095A61F2250/0018A61F2250/0026A61F2250/0065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,728
App. No.
14/791,617
Granted
Aug 9, 2016
Kind
B2
Abstract

A method of reducing blood flow within an aneurysm includes: injecting a contrast agent into a blood vessel including an aneurysm; deploying an occlusion device across the aneurysm; producing an image of the aneurysm including the contrast agent; and withdrawing the delivery device from the vessel after observing that the aneurysm has been obstructed by a desired amount. The image may be two-dimensional or three-dimensional. Observing that the aneurysm has been obstructed may include determining a degree of obstruction, for example by comparing an area or volume of the contrast agent in a first image and a second image. The desired amount may be a certain degree of obstruction, identification of a shape indicative of stasis such as a flat surface, an approximate hemisphere, a mushroom, or a crescent. If the occlusion device does not achieve the desired amount, a second occluding device may be deployed.

Claims (28)

1. A method of reducing blood flow within an aneurysm, the method comprising:

expanding a stent, from a delivery device, across the aneurysm, such that a stagnated area forms in the aneurysm;

injecting a contrast agent into a blood vessel comprising an aneurysm;

imaging the stagnated area forming a crescent shape, a mushroom shape, a hemispherical shape, and/or a flat side; and

while the stagnated area is in the crescent shape, withdrawing the delivery device from the vessel.

2. The method of claim 1 , wherein, after withdrawing the delivery device, substantially all of the aneurysm progressively thromboses.

3. The method of claim 1 , wherein the imaging is sufficient to determine that the expanding the stent is sufficient to lead to thrombosis of the aneurysm.

4. The method of claim 1 , wherein the imaging comprises imaging that the stagnated area fills less than 70% of a volume of the aneurysm.

5. The method of claim 1 , wherein the imaging comprises imaging that the stagnated area fills between about 20% and about 70% of a volume of the aneurysm.

6. The method of claim 1 , wherein the imaging comprises imaging that the stagnated area fills between about 50% and about 70% of a volume of the aneurysm.

7. The method of claim 1 , wherein the imaging comprises comparing a first image of the aneurysm before expanding the stent to a second image of the aneurysm after expanding the stent.

8. A method of reducing blood flow within an aneurysm, the method comprising:

expanding a stent, from a delivery device, across an aneurysm of a blood vessel, whereby a stagnated area forms into a crescent shape, a mushroom shape, a hemispherical shape, and/or a flat side in the aneurysm;

injecting a contrast agent into the blood vessel, at least a portion of the contrast agent flowing into the aneurysm; and

withdrawing the delivery device from the vessel upon imaging that the stagnated area forms the crescent shape, the mushroom shape, the hemispherical shape, and/or the flat side.

9. The method of claim 8 , wherein the imaging is sufficient to determine that the expanding the stent is sufficient to lead to thrombosis of the aneurysm.

10. The method of claim 8 , wherein the stagnated area fills less than 70% of a volume of the aneurysm when the delivery device is withdrawn from the vessel.

11. The method of claim 8 , wherein the stagnated area fills between about 20% and about 70% of a volume of the aneurysm when the delivery device is withdrawn from the vessel.

12. The method of claim 8 , wherein the stagnated area fills about 50% and about 70% of a volume of the aneurysm when the delivery device is withdrawn from the vessel.

13. A method of reducing blood flow within an aneurysm, the method comprising:

expanding a stent, from a delivery system, across the aneurysm;

injecting a contrast agent into a blood vessel comprising the aneurysm; and

withdrawing the delivery system from the vessel upon imaging that the aneurysm has stagnated by less than 70% of a volume of a body of the aneurysm, forming a stagnated area with a crescent shape, a mushroom shape, a hemispherical shape, and/or a flat side;

wherein, after withdrawing the delivery device, substantially all of the body progressively thromboses.

14. The method of claim 13 , further comprising withdrawing the stent from the vessel if the aneurysm does not thrombose by less than 70% of the volume of the body.

15. The method of claim 13 , wherein withdrawing the delivery device from the vessel comprises releasing the stent from the delivery device.

16. The method of claim 13 , further comprising expanding a second stent across the aneurysm.

17. The method of claim 16 , wherein expanding the second stent comprises expanding the second stent at least partially within the stent.

Assignments (5)
MERGER Recorded Oct 9, 2019
From: CHESTNUT MEDICAL TECHNOLOGIES, INC.
To: EV3 INC.
Reel/Frame 050665/0637 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: EV3 LLC
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 050665/0832 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: BEREZ, AARON LEE; TRAN, QUANG QUOC
To: CHESTNUT MEDICAL TECHNOLOGIES, INC.
Reel/Frame 050670/0156 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 050676/0380 →
CHANGE OF NAME Recorded Oct 9, 2019
From: EV3 INC.
To: EV3 LLC
Reel/Frame 051486/0422 →
Continuity (4)
Continuation 13652591 · Oct 16, 2012
Continuation 12751997 · Mar 31, 2010
Provisional Application 61288525 · Dec 21, 2009
Related Publication 20150305898A1 · Oct 29, 2015